CLN.WA
Price:
$19.84
Market Cap:
$1.07B
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-02-17
Stock Exchange
WSE
Ticker
CLN.WA
According to Celon Pharma S.A.’s latest financial reports and current stock price. The company's current ROE is -29.80%. This represents a change of 313.86% compared to the average of -7.20% of the last 4 quarters.
The mean historical ROE of Celon Pharma S.A. over the last ten years is 3.68%. The current -29.80% ROE has changed -909.90% with respect to the historical average. Over the past ten years (40 quarters), CLN.WA's ROE was at its highest in in the March 2016 quarter at 15.35%. The ROE was at its lowest in in the December 2024 quarter at -15.26%.
Average
3.68%
Median
1.21%
Minimum
-8.19%
Maximum
36.88%
Discovering the peaks and valleys of Celon Pharma S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 687.17%
Maximum Annual ROE = 36.88%
Minimum Annual Increase = -109.92%
Minimum Annual ROE = -8.19%
| Year | ROE | Change |
|---|---|---|
| 2024 | -7.74% | 22.58% |
| 2023 | -6.31% | -22.92% |
| 2022 | -8.19% | 290.85% |
| 2021 | -2.10% | 687.17% |
| 2020 | -0.27% | -109.92% |
| 2019 | 2.68% | -59.48% |
| 2018 | 6.62% | 13.64% |
| 2017 | 5.82% | -38.00% |
| 2016 | 9.39% | -74.53% |
| 2015 | 36.88% | -50.82% |
The current ROE of Celon Pharma S.A. (CLN.WA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.41%
5-year avg
-4.92%
10-year avg
3.68%
Celon Pharma S.A.’s ROE is greater than Ryvu Therapeutics S.A. (-89.88%), less than Voxel S.A. (27.72%), greater than Selvita S.A. (-0.91%), less than Scope Fluidics S.A. (41.59%), greater than Bioceltix S.A. (-45.44%), greater than Medicalgorithmics S.A. (-20.71%), greater than Bioton S.a. (-0.48%), less than Mercator Medical S.A. (2.69%), less than Centrum Medyczne ENEL-MED S.A. (8.97%), greater than NanoGroup S.A. (-57.44%),
| Company | ROE | Market cap |
|---|---|---|
| -89.88% | $605.74M | |
| 27.72% | $1.29B | |
| -0.91% | $798.46M | |
| 41.59% | $393.62M | |
| -45.44% | $390.99M | |
| -20.71% | $334.41M | |
| -0.48% | $335.73M | |
| 2.69% | $351.62M | |
| 8.97% | $514.70M | |
| -57.44% | $83.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celon Pharma S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celon Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Celon Pharma S.A.'s ROE?
How is the ROE calculated for Celon Pharma S.A. (CLN.WA)?
What is the highest ROE for Celon Pharma S.A. (CLN.WA)?
What is the 3-year average ROE for Celon Pharma S.A. (CLN.WA)?
What is the 5-year average ROE for Celon Pharma S.A. (CLN.WA)?
How does the current ROE for Celon Pharma S.A. (CLN.WA) compare to its historical average?